Vertex Pharmaceuticals Inc. said Jeffrey Chodakewitz, chief medical officer and executive vice president of global medicines development and medical affairs, will retire from his positions.

Chodakewitz, who joined Vertex in 2014, will remain with the Boston, Mass.-based company as a senior adviser through early 2019.

The developer of serious disease therapies named Reshma Kewalramani as chief medical officer and executive vice president of global medicines development and medical affairs, effective April 1.

Kewalramani serves as senior vice president of clinical development and medical affairs at Vertex.